Researchers note need to improve dental service use among US women of childbearing age

Oral diseases can be prevented or improved with regular dental visits. The objective of this study was to assess and compare national estimates on self-reported oral health conditions and dental visits among pregnant women and non-pregnant women of childbearing age by using data from the National Health and Nutrition Examination Survey (NHANES).

Researchers analyzed self-reported oral health information on 897 pregnant women and 3,971 non-pregnant women of childbearing age (15-44 years) from NHANES 1999-2004. They found disparities in self-reported oral health conditions and use of dental services among women regardless of pregnancy status. The percentage of women who reported having very good or good mouth and teeth condition was significantly higher among older pregnant women (aged 35-44 years) than among younger pregnant women (15-24 years). In contrast, the percentage of women who reported having very good or good mouth and teeth condition was significantly higher among younger non-pregnant women aged 15 to 24 than among older pregnant women aged 35 to 44.

Researchers note that the results highlight the need to improve dental service use among US women of childbearing age, especially young pregnant women, those who are non-Hispanic black or Mexican American, and those with low family income or low education level. Prenatal visits could be used as an opportunity to encourage pregnant women to seek preventive dental care during pregnancy.

Study: Oral Health Conditions and Dental Visits Among Pregnant and Nonpregnant Women of Childbearing Age in the United States, National Health and Nutrition Examination Survey, 1999-2004, Alejandro Azofeifa, DDS, MSc, MPH,Preventing Chronic Disease, published 18 September 2014.

http://www.medicalnewstoday.com/releases/282732.php

 

Association between widely used depression drug and dental implant failure

The International and American Associations for Dental Research (IADR/AADR) have published a paper titled “SSRIs and the Risk of Osseointegrated Implant Failure – A Cohort Study.” Selective Serotonin Reuptake Inhibitors (SSRIs), the most widely used drugs for the treatment of depression, have been reported to reduce bone formation and increase the risk of bone fracture. Since osseointegration is influenced by bone metabolism, this study investigates the association between SSRIs and the risk of failures in osseointegrated implants. The manuscript, by researchers Khadijeh Al-Abedalla, Samer Abi Nader, Belinda Nicolau, Emad Rastikerdar, Faleh Tamimi and Xixi Wu, from McGill University, Montreal, Quebec, Canada; and Nach Daniel, from East Coast Oral Surgery, Moncton, New Brunswick, Canada, is published in the OnlineFirst portion of the IADR/AADR Journal of Dental Research (JDR).

This retrospective cohort study was conducted on patients treated with dental implants from January 2007 to January 2013. A total of 916 dental implants in 490 patients (94 implants on 51 patients using SSRIs) were used to estimate the risk of failure associated with the use of SSRIs. Data analysis involved cox proportional hazards, generalized estimating equations models and Kaplan-Meier analysis. After three to 67 months of follow-up, 38 dental implants failed and 784 succeeded in nonusers group while 10 failed and 84 succeeded in SSRIs-users group.

The primary outcome was that compared with non-users of SSRIs, SSRIs usage was associated with an increased risk of dental implants failure (HR= 2∙31; P< 0∙01). The failure rates were 4.6% for SSRI non-users and 10.6% SSRI users, respectively. The secondary outcomes were that small implant diameters (≤4mm) (P=0∙01), bone augmentation (P=0∙04) and smoking habits (P<0∙01) also seemed to be associated with higher risk of implant failure. The main limitation of this retrospective study was that drug compliance dose and treatment period could not be acquired from the files of the patients.

Within the limits of this study, these findings indicate that treatment with SSRIs is associated with an increased failure risk of osseointegrated implants.

 

http://www.medicalnewstoday.com/releases/282056.php